Sociedad Americana de Hirudoterapia

The venomous cocktail of the vampire snail Colubraria reticulata (Mollusca, Gastropoda)

Comparative transcriptomics published in BMC Genomics (2015)

Última actualización: 18 de junio de 2026Revisado por: ASH Editorial Board
Artículo de investigación — revisión de la evidenciaReferencia del artículo
Evidencia: Preclínico (animal)Genómica y proteómicaFarmacología salivalModica MV et al. · BMC genomics, 2015

Resumen

BACKGROUND: Hematophagy arose independently multiple times during metazoan evolution, with several lineages of vampire animals particularly diversified in invertebrates. However, the biochemistry of hematophagy has been studied in a few species of direct medical interest and is still underdeveloped in most invertebrates, as in general is the study of venom toxins. In cone snails, leeches, arthropods and snakes, the strong target specificity of venom toxins uniquely aligns them to industrial and academic pursuits (pharmacological applications, pest control etc.) and provides a biochemical tool for studying biological activities including cell signalling and immunological response. Neogastropod snails (cones, oyster drills etc.) are carnivorous and include active predators, scavengers, grazers on sessile invertebrates and hematophagous parasites; most of them use venoms to efficiently feed. It has been hypothesized that trophic innovations were the main drivers of rapid radiation of Neogastropoda in the late Cretaceous. We present here the first molecular characterization of the alimentary secretion of a non-conoidean neogastropod, Colubraria reticulata. Colubrariids successfully feed on the blood of fishes, throughout the secretion into the host of a complex mixture of anaesthetics and anticoagulants. We used a NGS RNA-Seq approach, integrated with differential expression analyses and custom searches for putative secreted feeding-related proteins, to describe in detail the salivary and mid-oesophageal transcriptomes of this Mediterranean vampire snail, with functional and evolutionary insights on major families of bioactive molecules. RESULTS: A remarkably low level of overlap was observed between the gene expression in the two target tissues, which also contained a high percentage of putatively secreted proteins when compared to the whole body. At least 12 families of feeding-related proteins were identified, including: 1) anaesthetics, such as ShK Toxin-containing proteins and turripeptides (ion-channel blockers), Cysteine-rich secretory proteins (CRISPs), Adenosine Deaminase (ADA); 2) inhibitors of primary haemostasis, such as novel vWFA domain-containing proteins, the Ectonucleotide pyrophosphatase/phosphodiesterase family member 5 (ENPP5) and the wasp Antigen-5; 3) anticoagulants, such as TFPI-like multiple Kunitz-type protease inhibitors, Peptidases S1 (PS1), CAP/ShKT domain-containing proteins, Astacin metalloproteases and Astacin/ShKT domain-containing proteins; 4) additional proteins, such the Angiotensin-Converting Enzyme (ACE: vasopressive) and the cytolytic Porins. CONCLUSIONS: Colubraria feeding physiology seems to involve inhibitors of both primary and secondary haemostasis, anaesthetics, a vasoconstrictive enzyme to reduce feeding time and tissue-degrading proteins such as Porins and Astacins. The complexity of Colubraria venomous cocktail and the divergence from the arsenal of the few neogastropods studied to date (mostly conoideans) suggest that biochemical diversification of neogastropods might be largely underestimated and worth of extensive investigation.

Resumen tomado de PubMed (NCBI) para el registro citado, en el idioma original. La versión de referencia es la de la publicación original.

El resumen se deja sin traducir para conservar la redacción original de los autores.

Tipo de publicaciónJournal ArticleResearch Support, Non-U.S. Gov't
Términos MeSH indexadosAnimalsDatabases, GeneticEsophagusGastropodaGene Expression ProfilingMollusk VenomsOrgan SpecificitySalivary GlandsSequence Analysis, RNA

Síntesis

RNA-Seq of the salivary and mid-esophageal transcriptomes of the vampire snail Colubraria reticulata identified at least 12 families of secreted feeding-related proteins, including anaesthetics, anticoagulants such as Kunitz-type inhibitors, and inhibitors of primary haemostasis.

Contexto

Este estudio empleó transcriptómica RNA-Seq para caracterizar las secreciones salivales y del esófago medio del caracol vampiro Colubraria reticulata, identificando al menos 12 familias de proteínas relacionadas con la alimentación, entre ellas anestésicos, inhibidores de la hemostasia primaria, anticoagulantes y enzimas degradadoras de tejido. El caracol se alimenta de sangre de peces secretando un cóctel complejo en el hospedador. Este trabajo trata sobre un molusco gasterópodo, y el resumen menciona a las sanguijuelas solo como ejemplo comparativo de invertebrados hematófagos cuyas toxinas del veneno tienen relevancia farmacológica.

Citación

Referencia (estilo Vancouver)

Modica MV, Lombardo F, Franchini P, Oliverio M. The venomous cocktail of the vampire snail Colubraria reticulata (Mollusca, Gastropoda). BMC Genomics. 2015;16(1):441. doi:10.1186/s12864-015-1648-4. PMID: 26054852

Los datos bibliográficos (autores, volumen, páginas, DOI) proceden del registro de PubMed.

Contexto clínico relacionado

Investigación relacionada

Más estudios revisados por pares en la categoría «Genómica y proteómica».

Ver toda la investigación analizada por la ASH →

Añadido a la biblioteca ASH: 26 de mayo de 2026 · Última actualización del sitio: 18 de junio de 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.